SPDR S&P BIOTECH ETF's ticker is and the CUSIP is 78464A87R. A total of 1 filers reported holding SPDR S&P BIOTECH ETF in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $154,835 | +9.2% | 1,861 | 0.0% | 0.04% | +4.8% |
Q1 2023 | $141,826 | +4.6% | 1,861 | +14.0% | 0.04% | -2.3% |
Q4 2022 | $135,539 | +4.3% | 1,633 | 0.0% | 0.04% | -14.0% |
Q3 2022 | $130,000 | +7.4% | 1,633 | 0.0% | 0.05% | +13.6% |
Q2 2022 | $121,000 | +18.6% | 1,633 | +43.9% | 0.04% | +37.5% |
Q1 2022 | $102,000 | -1.9% | 1,135 | +22.2% | 0.03% | +6.7% |
Q4 2021 | $104,000 | -11.1% | 929 | 0.0% | 0.03% | -18.9% |
Q3 2021 | $117,000 | -7.1% | 929 | 0.0% | 0.04% | -5.1% |
Q2 2021 | $126,000 | 0.0% | 929 | 0.0% | 0.04% | -7.1% |
Q1 2021 | $126,000 | -3.8% | 929 | 0.0% | 0.04% | -6.7% |
Q4 2020 | $131,000 | +22.4% | 929 | -2.9% | 0.04% | +4.7% |
Q3 2020 | $107,000 | -18.3% | 957 | -18.2% | 0.04% | -20.4% |
Q2 2020 | $131,000 | +77.0% | 1,170 | +22.4% | 0.05% | +42.1% |
Q1 2020 | $74,000 | -18.7% | 956 | 0.0% | 0.04% | +2.7% |
Q4 2019 | $91,000 | +24.7% | 956 | 0.0% | 0.04% | +15.6% |
Q3 2019 | $73,000 | -13.1% | 956 | 0.0% | 0.03% | -15.8% |
Q2 2019 | $84,000 | -3.4% | 956 | 0.0% | 0.04% | -5.0% |
Q1 2019 | $87,000 | +26.1% | 956 | 0.0% | 0.04% | +11.1% |
Q4 2018 | $69,000 | -25.0% | 956 | 0.0% | 0.04% | -16.3% |
Q3 2018 | $92,000 | +1.1% | 956 | +0.1% | 0.04% | -4.4% |
Q2 2018 | $91,000 | +8.3% | 955 | 0.0% | 0.04% | +7.1% |
Q1 2018 | $84,000 | +3.7% | 955 | +0.1% | 0.04% | +5.0% |
Q4 2017 | $81,000 | -19.8% | 954 | -17.9% | 0.04% | -23.1% |
Q3 2017 | $101,000 | +12.2% | 1,162 | 0.0% | 0.05% | +8.3% |
Q2 2017 | $90,000 | +12.5% | 1,162 | +0.2% | 0.05% | +2.1% |
Q1 2017 | $80,000 | +15.9% | 1,160 | 0.0% | 0.05% | +11.9% |
Q4 2016 | $69,000 | -10.4% | 1,160 | 0.0% | 0.04% | -14.3% |
Q3 2016 | $77,000 | +22.2% | 1,160 | +0.1% | 0.05% | +16.7% |
Q2 2016 | $63,000 | +5.0% | 1,159 | +0.1% | 0.04% | +2.4% |
Q1 2016 | $60,000 | -25.9% | 1,158 | +0.1% | 0.04% | -32.8% |
Q4 2015 | $81,000 | +12.5% | 1,157 | +0.3% | 0.06% | +5.2% |
Q3 2015 | $72,000 | -25.8% | 1,154 | +200.5% | 0.06% | -20.5% |
Q2 2015 | $97,000 | +12.8% | 384 | +0.3% | 0.07% | +10.6% |
Q1 2015 | $86,000 | +21.1% | 383 | 0.0% | 0.07% | +15.8% |
Q4 2014 | $71,000 | +18.3% | 383 | +0.3% | 0.06% | +14.0% |
Q3 2014 | $60,000 | +1.7% | 382 | +0.3% | 0.05% | -9.1% |
Q2 2014 | $59,000 | +9.3% | 381 | +0.5% | 0.06% | +5.8% |
Q1 2014 | $54,000 | +10.2% | 379 | +0.3% | 0.05% | +8.3% |
Q4 2013 | $49,000 | – | 378 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Perkins Coie Trust Co | 1,633 | $121,000 | 0.04% |